Management of High-Grade Coronary Artery Disease and Concomitant Glanzmann Thrombasthenia
Katie P Truong1, Jessica J Zhang1, Marwah Shahid2
1Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
JACC. Case Reports
|November 3, 2021
Insights
This case report details managing severe coronary artery disease in a Glanzmann thrombasthenia patient. It highlights the lack of revascularization guidelines and offers new insights for complex patient care.
Area of Science:
- Cardiology
- Hematology
- Vascular Medicine
Background:
- Glanzmann thrombasthenia is a rare inherited bleeding disorder.
- Severe coronary artery disease (CAD) requires revascularization strategies.
- Managing CAD in patients with bleeding disorders presents unique challenges.
Observation:
- A patient with Glanzmann thrombasthenia presented with severe coronary artery disease.
- Standard revascularization guidelines are not established for this specific patient population.
- The case involved complex decision-making regarding treatment options.
Findings:
- The report describes the specific management approach undertaken for this patient.
- Novel discussion points regarding the nuanced care of such patients are presented.
- This case underscores the need for individualized treatment plans.
Implications:
- This case report may inform future clinical practice for patients with Glanzmann thrombasthenia and CAD.
- It highlights the importance of multidisciplinary collaboration in managing rare bleeding disorders with complex cardiovascular conditions.
- Further research is needed to establish evidence-based guidelines for revascularization in Glanzmann thrombasthenia patients.
Abstract:
In the present case report, we describe the management of severe coronary artery disease in a patient with Glanzmann thrombasthenia. To the best of our knowledge, there are no established guidelines for revascularization in this setting, and we pose novel discussion points regarding the nuanced care of this patient. (Level of Difficulty: Intermediate.).
Keywords:
ADP, adenosine diphosphateCABG, coronary artery bypass graftingCAD, coronary artery diseaseCCTA, coronary computed tomography angiographyDAPT, dual antiplatelet therapyDES, drug-eluting stentGT, Glanzmann thrombastheniaGlanzmann thrombastheniaLAD, left anterior descending coronary arteryLIMA, left internal mammary arteryPCI, percutaneous coronary interventioncoronary artery diseasedual antiplatelet therapypercutaneous coronary intervention
Related Concept Videos
01:27Coronary Artery Disease V: Interprofessional Care
67
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
67
01:26Mitral Stenosis III: Medical Management
43
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
43
01:21Rheumatic Heart Disease III: Medical Management
54
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
54
01:26Angina IV: Management
48
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
48
01:26Atherosclerosis III: Management
63
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
63
01:29Cardiomyopathy V: Interprofessional Care
65
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
65